Molecular Pathology
We utilise the latest research findings to assist clinicians with personalised cancer treatments and in combating complex diseases.
Fast and Precise Diagnostics
​
Rapid turnaround times and adherence to German standards of precision and accuracy.
To-the-Point, High-Quality Diagnostic Reports
​
High-quality reports that summarise relevant information concisely and precisely.
Evaluation by an Interdisciplinary Team
​
Findings are evaluated by a team comprising oncologists and pathologists.
Direct and Individual Consultation
​
Promptly available for professional consultations and personalised advice.
Tumor Tissue
Hot Spot Panel
Analysis of known hotspots to indicate approved therapies using Next-Generation Sequencing (NGS).
​
PanCancer Panel
A comprehensive genetic testing approach that simultaneously analyses a broad spectrum of genes associated with various cancer types. This identifies potential mutations and guides personalised treatment strategies, including off-label use and participation in available clinical studies (NGS).
​
MammaPrint
Gene expression analysis for breast cancer patients to assess the risk of metastasis and thus determine the necessity for chemotherapy.
Liquid Biopsy
​Hot Spot Panel
We utilise Next-Generation Sequencing (NGS) and digital droplet PCR (ddPCR) for the mutation analysis of cell-free DNA in the blood.
​
MRD Diagnostic via ddPCR
This method detects very low frequencies using digital droplet PCR (ddPCR) to measure minimal residual disease.
Connect With Us
